The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

A whole-food plant-based diet can significantly increase weight loss for men with prostate cancer and overweight or obesity ...

Johnson & Johnson’s PROTEUS Phase 3 trial shows apalutamide + hormone therapy before/after surgery improves outcomes in ...

Treatment regimen cut disease recurrence or death risk by 20% Researchers call data 'paradigm changing' J&J plans to seek expanded approvals for Erleada May 31 (Reuters) - Johnson & Johnson's (JNJ.N), ...

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...

With a new phase 3 win for Erleada (apalutamide), Johnson & Johnson is proposing a solution to a longstanding prostate cancer treatment gap. For patients with high-risk localized or locally advanced ...

As researchers in the laboratories and clinics of Fred Hutch Cancer Center strive to develop tomorrow’s cures for cancer, many are also pursuing innovative ways to improve the experience of people ...

Ceramides-lipid molecules in cells that affect many physiological functions including cell differentiation, migration, and ...

Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research ...

Doctor explains minimally invasive laser procedure removes enlarged prostate, reduces bleeding, and prevents kidney failure ...

A new study found that resistant prostate tumors can switch from male hormone signaling to cortisol pathways. The findings ...